Canna Care Docs
DECEMBER 16, 2020
According to a 2015 analysis of three studies of cancer patients, nausea and vomiting stopped for 47 percent of patients who used CBD or THC, while the same was only true for 20 percent of those who received a placebo. Research is ongoing, but the existing data and anecdotal reports show potential. Nausea and vomiting.
Cannabis Chronicles
FEBRUARY 15, 2019
Fairwinds employs more than 20 people, and Hull pointed to sales data showing their products were among the top sellers in Washington’s legal cannabis market last quarter, with over $4 million in retail sales. There are a lot of claims in the (cannabis) industry about what a product does: ‘This cures pain or epilepsy,’ ” Smith said.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
FEBRUARY 14, 2019
billion by 2020; the World Anti-Doping Agency eliminated the CBD from its list of banned substances; The Food and Drug Administration (FDA) for the first time approved a drug for epilepsy that contained CBD oil, prompting the US Drug Enforcement Administration to change its position about the CBD. billion dollars by 2022, with 1.3
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Veriheal
MAY 31, 2022
According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. The state legalized medical cannabis in 2015 via the Texas Compassionate Use Act , but very few residents qualified to use it for treatment. Expanded Qualifying Conditions.
Cannabis Law Report
DECEMBER 9, 2019
Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. However, as reported by New Frontier Data reports, there are two selling points that are overwhelmingly driving growth: reducing anxiety and reducing inflammation. Why so little research?
Veriheal
OCTOBER 5, 2020
The qualifying conditions for medical cannabis has been established in the bill as follows: Amyotrophic Lateral Sclerosis (ALS), Cachexia, Cancer, Chronic Pain, Crohn’s Disease, Epilepsy, Glaucoma, HIV/Aids, Lupus, Multiple Sclerosis, Nausea, Persistent Muscle Spasms, Post-traumatic Stress Disorder (PTSD), Rheumatoid Arthritis. .
Expert insights. Personalized for you.
52 
Let's personalize your content